Clarius Group LLC’s Rubius Therapeutics, Inc RUBY Stock Holding History

Clarius Group LLC’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,393	Closed	-$456	–	529
2023 Q1	$456	Hold	21,393	–	–	﹤0.01%	510
2022 Q4	$4K	Sell	21,393 -1,281	-6%	-$350	﹤0.01%	515
2022 Q3	$10K	Hold	22,674	–	–	﹤0.01%	493
2022 Q2	$19K	Buy	+22,674	New	+$38.1K	﹤0.01%	470

Clarius Group LLC's RUBY Position: Q2 2023 in Review

Clarius Group LLC sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2023, closing a stake of 21,393 shares — an estimated $456 sold.

Clarius Group LLC first reported a position in RUBY in Q2 2022 and held it in 4 quarters. The position peaked at $19K in Q2 2022. 0 funds tracked by Wall St. Rank hold RUBY as of Q2 2023.

Clarius Group LLC reported no remaining Rubius Therapeutics, Inc position as of Q2 2023 after selling out during the quarter.
Clarius Group LLC sold 21,393 Rubius Therapeutics, Inc shares in Q2 2023, an estimated $456.
Clarius Group LLC first reported a position in Rubius Therapeutics, Inc in Q2 2022 and held it in 4 quarters.
Clarius Group LLC's Rubius Therapeutics, Inc position peaked at $19K in Q2 2022.
0 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2023.

Based on Clarius Group LLC's 13F filing for Q2 2023, filed 10 Aug 2023.